StrataGraft Overlay of Meshed Autograft in Full-thickness Thermal Burns
Terminated · Phase 1, Phase 2 · NCT04765202
Conditions: Full Thickness Thermal Burn
At a glance
- Research payments reported, 2025
- $1,365
- U.S. investigators named
- 1
- Sites paid
- 1
- Planned or actual enrollment
- 13
About the trial
- Sponsor
- Stratatech, a Mallinckrodt Company
- Tested
- AG Tx (procedure), SOMA Tx (biological)
- Dates
- Started 2021-10-10; completion 2024-06-07
- Results posted
- Yes
Autografting is a surgical procedure to transplant healthy skin (donor skin) from another part of the participant's own body (donor site) to the burned part. Autografting is the usual treatment for full-thickness (FT) burns. It works to close the wound, but can cause other problems: * Donor sites are painful, can become infected or scarred, or can even become FT wounds themselves * Treatment problems can require more grafting * Additional surgery increases risk of medical problems caused by the treatment Stratatech is trying to find a safe and effective treatment option for severe burns that uses less donor skin. All participants in this study received meshed autograft on one part of thei…
From ClinicalTrials.gov, last updated 2025-05-16. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Mallinckrodt Hospital Products Inc. reported $1,365 in research payments for this study in 2025 (1 payments).
Products named: Stratagraft
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Medical University of South Carolina $1,365
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.